capsaicin has been researched along with eriodictyol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Athayde, ML; de Oliveira, AP; Ferreira, J; Gomez, MV; Klafke, JZ; Rossato, MF; Royes, LF; Trevisan, G; Villarinho, JG; Walker, CI; Zanon, RB | 1 |
2 other study(ies) available for capsaicin and eriodictyol
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Eriodictyol: a flavonoid antagonist of the TRPV1 receptor with antioxidant activity.
Topics: Analgesics; Animals; Antioxidants; Capsaicin; Flavanones; Flavonoids; Hyperalgesia; Mice; Pain; Rats; TRPV Cation Channels | 2011 |